Guardant Health
GH
#1531
Rank
HK$105.24 B
Marketcap
HK$810.38
Share price
2.11%
Change (1 day)
186.40%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Net assets

Net assets on the balance sheet as of September 2025 : -HK$2.76 Billion

According to Guardant Health 's latest financial reports the company has -HK$2.76 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Guardant Health - Net assets on balance sheet (from 2017 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-HK$1.09 Billion-187.48%
2023-12-31$HK$1.23 B163.57%
2022-12-31$HK$0.47 B-90.65%
2021-12-31$HK$5.02 B-52.14%
2020-12-31$HK$10.50 B59.12%
2019-12-31$HK$6.60 B60.65%
2018-12-31$HK$4.11 B70.5%
2017-12-31$HK$2.41 B290.15%
2016-12-31$HK$0.61 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Natera
NTRA
HK$9.74 B-453.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
HK$16.48 B-697.69%๐Ÿ‡บ๐Ÿ‡ธ USA